Axios @axios
Trump administration officials fought over whether — and ultimately declined — to fund the same antiviral drug that Merck announced yesterday significantly reduces hospitalizations and deaths among coronavirus patients. https://t.co/KkbEg5i0h1 — PolitiTweet.org